Janney Montgomery Scott’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Buy |
20,330
+76
| +0.4% | +$1.65K | ﹤0.01% | 2089 |
|
|
2025
Q1 | $491K | Sell |
20,254
-3,075
| -13% | -$74.5K | ﹤0.01% | 1994 |
|
|
2024
Q4 | $487K | Buy |
23,329
+407
| +2% | +$8.5K | ﹤0.01% | 2016 |
|
|
2024
Q3 | $456K | Hold |
22,922
| – | – | ﹤0.01% | 2034 |
|
|
2024
Q2 | $355K | Buy |
22,922
+75
| +0.3% | +$1.16K | ﹤0.01% | 2117 |
|
|
2024
Q1 | $364K | Buy |
22,847
+37
| +0.2% | +$589 | ﹤0.01% | 2208 |
|
|
2023
Q4 | $383K | Sell |
22,810
-850
| -4% | -$14.3K | ﹤0.01% | 2082 |
|
|
2023
Q3 | $277K | Sell |
23,660
-462
| -2% | -$5.41K | ﹤0.01% | 2180 |
|
|
2023
Q2 | $324K | Sell |
24,122
-23,621
| -49% | -$317K | ﹤0.01% | 2177 |
|
|
2023
Q1 | $792K | Buy |
47,743
+4,939
| +12% | +$81.9K | ﹤0.01% | 1440 |
|
|
2022
Q4 | $796K | Buy |
42,804
+25,032
| +141% | +$466K | ﹤0.01% | 1488 |
|
|
2022
Q3 | $228K | Hold |
17,772
| – | – | ﹤0.01% | 2195 |
|
|
2022
Q2 | $122K | Buy |
17,772
+1,000
| +6% | +$6.87K | ﹤0.01% | 2218 |
|
|
2022
Q1 | $139K | Buy |
+16,772
| New | +$139K | ﹤0.01% | 2154 |
|
|
2014
Q4 | – | Sell |
-10,000
| Closed | -$33.2K | – | 2332 |
|
|
2014
Q3 | $33.2K | Hold |
10,000
| – | – | ﹤0.01% | 2249 |
|
|
2014
Q2 | $25.3K | Hold |
10,000
| – | – | ﹤0.01% | 2187 |
|
|
2014
Q1 | $22.6K | Hold |
10,000
| – | – | ﹤0.01% | 2015 |
|
|
2013
Q4 | $19.5K | Buy |
+10,000
| New | +$19.5K | ﹤0.01% | 1985 |
|